Wegovy (semaglutide) is a GLP-1 receptor agonist that’s ... Based on a study sponsored by Zepbound's manufacturer, Eli Lilly, people without diabetes taking 5 mg of Zepbound weekly lost an average of ...
With Wegovy gaining acceptance for China in Q2 2024 ... R&D for a genetic based obesity drug is currently in the works by ...